Navigation Links
Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential
Date:3/4/2013

, Spain, Revenue Forecast ($m), 2011-2019 30
Figure 23: Idiopathic Thrombocytopenic Purpura, Japan, Revenue Forecast ($m), 2011-2019 31
Figure 24: Idiopathic Thrombocytopenic Purpura, Total Market, Average Annual Cost of Therapy (%), 2011-2019 32
Figure 25: Idiopathic Thrombocytopenic Purpura, Treatment Usage Pattern ('000), 2011-2019 33
Figure 26: Idiopathic Thrombocytopenic Purpura, Pipeline Overview 35
Figure 27: Idiopathic Thrombocytopenic Purpura, Pipeline, Phase I by Therapeutic Class 36
Figure 28: Idiopathic Thrombocytopenic Purpura, Pipeline, Phase II Molecule Comparison 37
Figure 29: Idiopathic Thrombocytopenic Purpura, Pipeline, Phase III Molecule Comparison 39
Figure 30: Idiopathic Thrombocytopenic Purpura, Pipeline by Therapeutic Class 40
Figure 31: Idiopathic Thrombocytopenic Purpura, Pipeline by Molecule Type 40
Figure 32: Idiopathic Thrombocytopenic Purpura, Pipeline by Mechanism of Action 41
Figure 33: Myelodysplastic Syndrome, Total Market, Revenue Forecast ($m), 2011-2019 45
Figure 34: Myelodysplastic Syndrome, US, Revenue Forecast ($m), 2011-2019 46
Figure 35: Myelodysplastic Syndrome, UK, Revenue Forecast ($m), 2011-2019 46
Figure 36: Myelodysplastic Syndrome, France, Revenue Forecast ($m), 2011-2019 47
Figure 37: Myelodysplastic Syndrome, Germany, Revenue Forecast ($m), 2011-2019 47
Figure 38: Myelodysplastic Syndrome, Italy, Revenue Forecast ($m), 2011-2019 48
Figure 39: Myelodysplastic Syndrome, Spain, Revenue Forecast ($m), 2011-2019 48
Figure 40: Myelodysplastic Syndrome, Japan, Revenue Forecast ($m), 2011-2019 49
Figure 41: Myelodysplastic Syndrome, Total Market, Average Annual Cost of Therapy (%), 2011-2019 50
Figure 42: Myelodysplastic Syndrome, Treatment Usage Pattern ('000), 2011
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Founder of Nestle-Acquired Company Joins Prismic Pharmaceuticals
2. Young Innovations Announces Definitive Agreement to be Acquired by Linden Capital Partners
3. Bandages Plus, Inc. Doral, Florida has been acquired by The Morrissey Group, LLC
4. Pathogenica and Life Technologies EMEA Partner to Control Hospital Acquired Infections
5. Medisafe 1 Technologies Corp has of Today Acquired 3,100,000 Shares and Continues to Acquire Shares Under its $1MM Stock Repurchase Program of 10MM Shares up to 10 Cents a Share to Facilitate its On-going Acquisitions Activity Plan
6. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
7. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
8. FDA Grants Orphan Drug Status To Eisais Lenvatinib
9. Lentigen Receives U.S. Orphan Drug Designation for Novel Gene Therapy for glioblastoma multiforme
10. BHR Pharma Investigational Traumatic Brain Injury Treatment Receives European Medicines Agency Orphan Medicinal Product Designation
11. Inherited Orphan Blood Disorders Therapeutics Market to 2019 - Breakthrough Drugs Remain Elusive Against Backdrop of High Unmet Need
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... N.J. , March 27, 2015  Johnson & Johnson ... Shareholders at 10 a.m. (Eastern Time) on Thursday, April 23, ... N.J. Investors and other interested parties ... visiting the Company,s website at www.jnj.com and clicking ... from the meeting will be made available a few hours ...
(Date:3/27/2015)... March 27, 2015 RnRMarketResearch.com ... therapeutic market research report of 52 pages with ... business intelligence library. The report "Visceral ... the therapeutic development for Visceral Pain, complete with ... drug target, mechanism of action (MoA), route of ...
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, ... and medical device company focused on oncology with ... metastatic liver cancers, announces the reporting of data ... Melphalan Hydrochloride for Injection with the Delcath Hepatic ... poster presentation at the Society of Surgical Oncology ...
Breaking Medicine Technology:Visceral Pain Pipeline Review H1 2015 Market Research Report 2Visceral Pain Pipeline Review H1 2015 Market Research Report 3Visceral Pain Pipeline Review H1 2015 Market Research Report 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5
... This evening, Novo Nordisk awarded sponsorships totaling $100,000 to ... people living with type 2 diabetes on how to ... long-term diabetes related complications. The sponsorships are part of ... promote enduring, sustainable change for people living with diabetes. ...
... Cadence Pharmaceuticals, Inc. (NASDAQ: CADX ), ... proprietary product candidates principally for use in the hospital ... corporate overview at the following investment conferences: , ... , Wednesday, September 7, 2011Time:   , 1:30pm Eastern ...
Cached Medicine Technology:Novo Nordisk Partners with Minneapolis Community Groups to Support Diabetes Education Programs 2Cadence Pharmaceuticals to Present at Three Investment Conferences During the Month of September 2011 2
(Date:3/27/2015)... USA (PRWEB) March 27, 2015 According ... rates of newborns born with Neonatal Abstinence Syndrome (NAS) ... NAS will undergo the painful withdrawal process for a ... body tremors, excessive crying, diarrhea, and vomiting. The condition ... undergoing drug and alcohol addiction treatment (and employing medically ...
(Date:3/27/2015)... London, UK (PRWEB) March 27, 2015 ... that it has appointed Sean Fitzgerald, a former technology ... Chief Operating Officer and Interim Chief Financial Officer. , ... leading education technology innovator, EverFi, backed by Amazon founder ... Twitter founder Evan Williams. Prior to EverFi, he was ...
(Date:3/27/2015)... 2015 SMI (Silicon Microstructures, Inc.), a ... launched the SM1120 MEMS based ultra-miniature pressure sensor designed ... profile at only 220um x 75um provides ample space ... locations. With industry leading in vivo drift performance ... a broad operating pressure range from 0 to 1,100 ...
(Date:3/27/2015)... Diego, CA (PRWEB) March 27, 2015 ... launch its Protect Our Children (POC) NOW! vitamin D ... the Medical University of South Carolina (MUSC), and will ... will be available at no cost to a minimum ... gestation who live within these two service areas. The ...
(Date:3/27/2015)... 2015 California’s ongoing worst ever drought, ... and the United States Northeast, are both manifestations of ... atmosphere is creating changes in the atmosphere’s “energy balance,” ... former NASA researcher, speaking on the Sharon Kleyne Hour™ ... only a warmer and dryer global climate but also ...
Breaking Medicine News(10 mins):Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3
... of two drugs delays disease progression for patients with ... Phase III "ATLAS" trial were presented today by Dr. ... the American Society of Clinical Oncology Annual Meeting. ... whether adding erlotinib (Tarceva), a targeted agent, to maintenance ...
... movers can help reduce risk of serious injury , , SATURDAY, ... movers can help you reduce the risk of injury the ... 20 men who carried a load on a treadmill so ... back, abdomen and forearms. , The study found that carrying ...
... in Heart Failure (HF) syndrome either in stable chronic ... are used to diagnose disease risk, to predict outcome ... a press conference at Heart Failure 2009 in Nice, ... of Cardiology, presented these new findings, namely: , ...
... accessible mini-van and will give it away to a deserving family or ... to ensure this message reaches any family or organization that would benefit ... ... 30, 2009 -- Hyundai of Tempe has acquired a wheelchair ...
... Austin, M.D., founder, Executive Chairman and Chief Medical ... an airplane accident on May 29th, 2009. According ... Sheriff,s Office, his private plane, a Storch two-seater, ... legacy includes leading Arcadian Management Services, a provider ...
... Pharmaceuticals Inc. (Nasdaq: VNDA ) announced today that ... Thursday, August 27, 2009, in Rockville, Maryland. The record ... Only stockholders of record at the close of business ... any adjournment thereof. Vanda anticipates mailing its proxy statement ...
Cached Medicine News:Health News:Study shows drug combination improves outcome for advanced non-small cell lung cancer 2Health News:When It Comes to Lifting, the Pros Have Your Back 2Health News:Novel biomarkers in heart failure 2Health News:Hyundai of Tempe to Giveaway Wheelchair Van to Deserving Family 2Health News:Plane Crash Claims Arcadian's Chairman and Founder, John H. Austin M.D. 2
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
... The unmatched performance of CLS restores ... optimal hemodynamics even when the patient is ... concept of prevention, early detection and restoration ... button) programming and patient management via Home ...
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
Medicine Products: